The multi-targeted kinase inhibitor Sorafenib inhibits Enterovirus 71 IRES activity

被引:0
作者
Peng, Y. [1 ]
Gao, M. [1 ]
Wang, X. [1 ]
Zhu, M. [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China
关键词
D O I
10.1016/j.ijid.2014.03.1356
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
64.026
引用
收藏
页码:453 / 453
页数:1
相关论文
共 50 条
[31]   Dasatinib (BMS-354825), a multi-targeted kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane and activation loop mutant kit isoforms associated with human malignancies [J].
Schittenhelm, MM ;
Shiraga, S ;
Schroeder, A ;
Corbin, AS ;
Griffith, D ;
Lee, FY ;
Deininger, MW ;
Druker, BJ ;
Heinrich, MC .
BLOOD, 2005, 106 (11) :938A-939A
[32]   Large open-label, non-comparative, clinical experience trial of the multi-targeted kinase inhibitor sorafenib in European patients with advanced RCC [J].
Beck, J. ;
Procopio, G. ;
Verzoni, E. ;
Negrier, S. ;
Keilholz, U. ;
Szczylik, C. ;
Mersmann, S. ;
Burock, K. ;
Huber, C. ;
Escudier, B. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[33]   A novel selective multi-targeted tyrosine kinase inhibitor with superior anti-tumor efficacy [J].
Hjarnaa, P. ;
Fensholdt, Jef .
INFLAMMATION RESEARCH, 2007, 56 :S464-S465
[34]   Preclinical development of a novel multi-targeted kinase inhibitor, MG516, for the treatment of sarcoma [J].
Ivy, Kathryn S. ;
Patwardhan, Parag P. ;
Schwartz, Gary K. .
CANCER RESEARCH, 2014, 74 (19)
[35]   MULTI-TARGETED TYROSINE KINASE INHIBITORS PLUS CHEMOTHERAPY [J].
Ivy, S. P. ;
Chen, H. .
ANNALS OF ONCOLOGY, 2009, 20 :25-25
[36]   AT-9283, a small-molecule multi-targeted kinase inhibitor for the potential treatment of cancer [J].
Kimura, Shinya .
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (12) :1442-1449
[37]   THE MULTI-TARGETED KINASE INHIBITOR DASATINIB IMPROVES OUTCOMES AFTER TRAUMATIC BRAIN INJURY IN RATS [J].
Lui, Austin ;
Gann, Meghan ;
Vanleuven, Jordan ;
Liu, Dewey ;
Shahlaie, Kiarash ;
Martin, Ryan ;
Lyeth, Bruce ;
Liu, Dazhi .
JOURNAL OF NEUROTRAUMA, 2023, 40 (15-16) :A56-A56
[38]   ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside [J].
Jianbiao Zhou ;
Boon-Cher Goh ;
Daniel H Albert ;
Chien-Shing Chen .
Journal of Hematology & Oncology, 2
[39]   TKI258, a novel, multi-targeted tyrosine kinase inhibitor for the treatment of breast cancer [J].
Liu, Hongyu ;
Dieing, Annette ;
Lehenbauer-Dehm, Sylvia ;
Kuehnhardt, Dagmar ;
Regierer, Anne ;
Schulz, Carsten ;
Storek, Benjamin ;
Schwarck, Sandra ;
Possinger, Kurt ;
Eucker, Jan .
CANCER RESEARCH, 2009, 69
[40]   The Multi-Targeted Kinase Inhibitor Sunitinib Induces Apoptosis in Colon Cancer Cells via PUMA [J].
Sun, Jing ;
Sun, Quanhong ;
Brown, Matthew F. ;
Dudgeon, Crissy ;
Chandler, Julie ;
Xu, Xiang ;
Shu, Yongqian ;
Zhang, Lin ;
Yu, Jian .
PLOS ONE, 2012, 7 (08)